Standout Papers

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuxim... 2007 2026 2013 2019 607
  1. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy (2007)
    Frédéric Di Fiore, Frédéric Blanchard et al. British Journal of Cancer

Immediate Impact

11 from Science/Nature 78 standout
Sub-graph 1 of 19

Citing Papers

Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
5 intermediate papers

Works of A. Lamy being referenced

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
2007 Standout
Molecular Profiling of Bladder Tumors Based on the Detection of FGFR3 and TP53 Mutations
2006

Author Peers

Author Last Decade Papers Cites
A. Lamy 634 160 261 299 9 768
V. Martin 669 193 270 343 10 793
Jef De Schutter 675 158 229 337 7 782
M. Janssens 604 118 244 277 6 677
Seta Shahin 794 120 143 315 13 925
Frédérique Maindrault‐Gœbel 740 139 142 290 14 939
Christopher Hagenstad 673 168 149 293 14 832
Tarek Chidiac 783 202 136 378 16 985
Minaxi Jhawer 476 302 167 376 13 829
B. Lueza 574 64 229 293 19 760
Zhi-Qin Jiang 553 331 243 269 12 862

All Works

Loading papers...

Rankless by CCL
2026